France advises AstraZeneca vaccine only for those under 65

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"1">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p>France’s top health advisory body is recommending that the AstraZeneca coronavirus vaccine only be used on people under 65&comma; citing lack of sufficient data about its effectiveness in older people&period;<&sol;p>&NewLine;<p>The decision could shake up the French vaccination strategy&comma; because the country has prioritised nursing home residents and people over 75&period;<&sol;p>&NewLine;<p>France had counted on the AstraZeneca vaccine for a large part of its upcoming inoculations&comma; until the company announced delays affecting countries around Europe and the world&period;<&sol;p>&NewLine;<p>The French guidance differs from that given by the European Medicines Agency&comma; which authorised AstraZeneca’s vaccine for use in all adults throughout the European Union on Friday&comma; amid criticism the bloc is not moving fast enough to vaccinate its population&period;<&sol;p>&NewLine;<p>Health authorities in Germany and other countries have raised concerns that the Anglo-Swedish company did not test the vaccine in enough older people to prove it works for them&comma; and indicated they would not recommend it for people over 65&period;<&sol;p>&NewLine;<p>In guidance issued on Tuesday&comma; France’s High Authority for Health said it &OpenCurlyDoubleQuote;recommends that the vaccine… be given preferentially to people under 65”&period;<&sol;p>&NewLine;<p>It says it will review this guidance when AstraZeneca has more data on the vaccine’s effectiveness in older people&period;<&sol;p>&NewLine;<p>The French government depends on the High Authority’s guidance&comma; and will announce on Wednesday how this affects its plans&period; Health officials have said they constantly adapt vaccine strategy based on availability of doses&comma; demand and regulatory guidance&period;<&sol;p>&NewLine;<p>President Emmanuel Macron met on Tuesday night with international vaccine producers and major pharmaceutical companies that have an industrial site in France to discuss ways to &OpenCurlyDoubleQuote;quickly” and &OpenCurlyDoubleQuote;significantly” boost short-term production capabilities in France and in Europe&period;<&sol;p>&NewLine;<p>The meeting comes amid criticism of the EU’s handling of its collective vaccine strategy across the 27 member states&period;<&sol;p>&NewLine;<p>France has seen among the world’s highest numbers of virus infections and deaths&comma; which have been steadily rising in recent weeks&period;<&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-68ed5ecfc5828">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-68ed5ecfc5828'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -
Exit mobile version